Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsThe authors summarize currently approved tyrosine kinase inhibitors for HER2+ breast cancer, key clinical trials, and their use in current clinical practice.
[npj Breast Cancer]
Home Newsletters Mammary Cell News HER2-Positive Breast Cancer and Tyrosine Kinase Inhibitors: The Time Is Now
